BARBARA KERBY: Open Payments
NPI 1326264953 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 18 payments from 7 companies in 2025. Trend: 2023 $348 · 2024 $291 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $124 |
| Lilly USA, LLC | 5 | $95 |
| Novo Nordisk Inc | 2 | $41 |
| PFIZER INC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: MOUNJARO, OTEZLA, EVENITY, Ozempic, PREVNAR 20, Wegovy, NEXLETOL, SHINGRIX.
Industry payments across MS — which companies pay providers there.
